Bilirubin rate of rise during routine 6-h transcutaneous bilirubin surveillance

Area of Science:

• Neonatal Medicine
• Pediatric Neonatology
• Clinical Chemistry

Background:

• Hyperbilirubinemia is common in newborns.
• Early detection of rapid bilirubin rise is crucial to prevent kernicterus.
• Transcutaneous bilirubinometry (TcB) is a non-invasive screening tool.

Purpose of the Study:

• To assess the clinical utility of routine 6-hour TcB surveillance.
• To evaluate the impact of TcB surveillance on bilirubin rate-of-rise (ROR) values meeting American Academy of Pediatrics (AAP) criteria.
• To determine the specificity of AAP ROR cut-points for identifying hemolytic hyperbilirubinemia neurotoxicity risk factors (HNRFs).

Main Methods:

• Retrospective cohort study of healthy newborns (≥35 weeks gestation, ≥2.0 kg).
• Routine 6-hour TcB monitoring during birth hospitalization.
• ROR calculated from consecutive TcB measurements, assessed as a screening test for HNRFs.

Main Results:

• 71.8% of 621 newborns met ≥1 AAP ROR cut-point.
• Variable TcB trajectories were common, with nearly 25% preceded by a negative slope.
• Extending surveillance to 12 hours reduced the odds of meeting AAP ROR cut-points by ~60%.
• AAP ROR cut-points showed moderate sensitivity (73%) but low specificity (28%) for HNRFs.

Conclusions:

• Routine 6-hour TcB surveillance frequently generates AAP ROR cut-points.
• The low specificity of these cut-points for HNRFs limits their clinical utility for short-interval ROR assessment.
• Extending TcB surveillance duration may enhance its screening performance.